Literature DB >> 6143826

Alpha-adrenoreceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity.

C B Chapleo, P L Myers, R C Butler, J A Davis, J C Doxey, S D Higgins, M Myers, A G Roach, C F Smith, M R Stillings.   

Abstract

Modification of the 1,4-benzodioxan ring present in RX 781094 has not previously been considered. This paper describes a number of analogues of this ring system, including compounds in which one of the oxygen atoms has been replaced by a methylene group and also those in which the ring size has been changed to give, for example, furan and thiophene derivatives. The dihydrobenzofuranylimidazoline compound 7 is the only analogue possessing presynaptic antagonist potency potency and selectivity comparable to that of 1. In view of this result, a number of derivatives was prepared to determine the structure-activity relationships within this series. Many derivatives, as well as the parent compound 7, were found to possess presynaptic alpha 2-adrenoreceptor antagonist and postsynaptic alpha 1-adrenoreceptor partial agonist properties. Two of the selective presynaptic antagonists, 13 and 14 possess greater potency and selectivity than that possessed by 1. The 5-chloro derivative 25 is twice as potent as after oral administration but only about half as potent when given intravenously.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143826     DOI: 10.1021/jm00371a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.

Authors:  A U Trendelenburg; C A Wahl; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

3.  The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat.

Authors:  H C Jackson; I J Griffin; D J Nutt
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Exploring the pharmacology of the pro-convulsant effects of alpha 2-adrenoceptor antagonists in mice.

Authors:  H C Jackson; S L Dickinson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites.

Authors:  C A Brown; A C Loweth; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

6.  Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.

Authors:  C A Brown; S L Chan; M R Stillings; S A Smith; N G Morgan
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 7.  Fragment-based drug discovery: opportunities for organic synthesis.

Authors:  Jeffrey D St Denis; Richard J Hall; Christopher W Murray; Tom D Heightman; David C Rees
Journal:  RSC Med Chem       Date:  2020-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.